Objective: The paper analyzes the implementation status of "dual channel" management of national negotiated drugs in S Province, analyzes the factors affecting the availability, so as to provide reference for governments to improve relevant policies, the availability of drugs for patients. Methods: The data were collected from the S Province State-negotiated Drug Monitoring Platform, the official policy documents, reports were investigated, the availability analysis was conducted using Excel, WHO/HAI standard survey method. Results: The "dual channel" management of state-negotiated drugs in S Province achieved initial results, the overall availability of drugs was improving, but there were differences among institutions, diseases, the availability of specific varieties was generally low. The factors affecting accessibility included policy coordination, medical institution diagnosis, treatment level, information system construction. Conclusions: It is suggested to improve the construction of medical institutions, coordinate regional development, establish communication, coordination mechanism, strengthen supervision, management, establish an accessibility index system, carry out systematic evaluation on a regular basis, strengthen policy publicity, education
Key words
dual channel /
state-negotiated drugs /
WHO/HAI standard survey method /
availability
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 张博,丁锦希,陈烨,等.国家医保谈判药品“双通道”政策动因与实施模式[J].世界临床药物,2021,42(09):709-716.
[2] 管晓东,史录文.基于WHO/HAI标准调查法的我国基本药物可及性评价方法研究[J].中国药房,2013,24(24):2212-2215.
[3] Shanti M,Keiko F,Alexandr C,et al.The availability and affordability of selected essential medicines for chronic diseases in six low-and-middle-income countries[J]. Bulletin of the World Health Organization,2007,85(4):279.
[4] 刘芸男,彭荣荣,杨小丽.实现我国罕见病药品可及性的困境与对策研究[J].中国卫生经济,2020,39(06):30-32.
[5] 陈玲玲,徐伟,尚波波,等.国谈药可获得性研究——基于苏州市公立医院采购数据的实证分析[J].卫生经济研究,2020,37(12):17-20.
[6] 陈金燃,郭凯宁,陈纯,等.2018-2019年福建省国谈药患者用药可及性调研分析[J].中国医疗保险,2020(12):59-64.
[7] 张钰婉,谈在祥,卢亚娟.国谈药“双通道”模式实施现状及优化建议——以S市为例[J].卫生经济研究,2022,39(04):15-18+23.
[8] 谢金平,邵蓉.国家医保谈判药品省级落地管理典型模式研究[J].中国卫生经济,2020,39(06):42-46.
[9] 廖彬池,胡明,周乃彤,等.基本药物可及性评价指标体系研究[J].中国药房,2016,27(18):2449-2451.